dc.contributor.author | Oflaz, H | |
dc.contributor.author | Buyukozturk, K | |
dc.contributor.author | Sezer, A | |
dc.contributor.author | Adalet, K | |
dc.date.accessioned | 2021-03-06T11:14:00Z | |
dc.date.available | 2021-03-06T11:14:00Z | |
dc.date.issued | 2001 | |
dc.identifier.citation | Adalet K., Oflaz H., Sezer A., Buyukozturk K., "Efficacy and tolerability of fixed, low-dose combination therapy with verapamil sustained-release and trandolapril in patients with mild to severe essential hypertension uncontrolled by monotherapy: An open-label, multicenter trial", CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, cilt.62, ss.261-271, 2001 | |
dc.identifier.issn | 0011-393X | |
dc.identifier.other | av_ee11371c-615b-4b3f-b5a7-5b9a97d7d5d4 | |
dc.identifier.other | vv_1032021 | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/156297 | |
dc.identifier.uri | https://doi.org/10.1016/s0011-393x(01)80010-2 | |
dc.description.abstract | Background: Only 40% to 60% of patients with essential hypertension respond adequately to antihypertensive monotherapy. The combination of an angiotensin-converting enzyme inhibitor and a calcium antagonist, both of which have tissue-protective properties but different mechanisms of action, may lead to an additive antihypertensive effect. | |
dc.language.iso | eng | |
dc.subject | Dahili Tıp Bilimleri | |
dc.subject | Tıbbi Ekoloji ve Hidroklimatoloji | |
dc.subject | Eczacılık | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Tıp | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Klinik Tıp (MED) | |
dc.subject | Klinik Tıp | |
dc.subject | TIP, ARAŞTIRMA VE DENEYSEL | |
dc.title | Efficacy and tolerability of fixed, low-dose combination therapy with verapamil sustained-release and trandolapril in patients with mild to severe essential hypertension uncontrolled by monotherapy: An open-label, multicenter trial | |
dc.type | Makale | |
dc.relation.journal | CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL | |
dc.contributor.department | , , | |
dc.identifier.volume | 62 | |
dc.identifier.issue | 4 | |
dc.identifier.startpage | 261 | |
dc.identifier.endpage | 271 | |
dc.contributor.firstauthorID | 161623 | |